Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,348
Closed -$349K 39
2019
Q3
$349K Buy
+4,348
New +$348K 5.05% 5
2018
Q1
Sell
-9,388
Closed -$504K 162
2017
Q4
$504K Buy
+9,388
New +$520K 2.09% 6
2016
Q3
Sell
-4,484
Closed -$247K 297
2016
Q2
$247K Buy
+4,484
New +$239K 0.11% 173

Other funds holding MRK

QCM Cayman's MRK Position: Q4 2019 in Review

QCM Cayman sold out of Merck (MRK) in Q4 2019, closing a stake of 4,348 shares — an estimated $349K sold.

QCM Cayman first reported a position in MRK in Q2 2016 and held it in 3 quarters. The position peaked at $504K in Q4 2017. 2,537 funds tracked by Wall St. Rank hold MRK as of Q4 2019.

  • QCM Cayman reported no remaining Merck position as of Q4 2019 after selling out during the quarter.
  • QCM Cayman sold 4,348 Merck shares in Q4 2019, an estimated $349K.
  • QCM Cayman first reported a position in Merck in Q2 2016 and held it in 3 quarters.
  • QCM Cayman's Merck position peaked at $504K in Q4 2017.
  • 2,537 funds tracked by Wall St. Rank held Merck as of Q4 2019.

Based on QCM Cayman's 13F filing for Q4 2019, filed 14 Feb 2020.